clonazepam has been researched along with allopurinol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Callahan, AS; Christie-Pope, BC; Eddy, LJ; Palmer, GC; Palmer, SJ; Taylor, MD | 1 |
Allen, LV; Erickson, MA | 1 |
Jornot, L; Junod, AF; Maechler, P; Wollheim, CB | 1 |
1 review(s) available for clonazepam and allopurinol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for clonazepam and allopurinol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Classification of ischemic-induced damage to Na+, K+-ATPase in gerbil forebrain. Modification by therapeutic agents.
Topics: Adenosine Triphosphatases; Allopurinol; Animals; Brain; Brain Ischemia; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Clonazepam; Egtazic Acid; Female; Gerbillinae; Indomethacin; Methylprednisolone; Sodium-Potassium-Exchanging ATPase; Thiopental; Time Factors | 1985 |
Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
Topics: Acetazolamide; Allopurinol; Azathioprine; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Clonazepam; Drug Combinations; Drug Compounding; Drug Incompatibility; Drug Stability; Flucytosine; Hydrogen-Ion Concentration; Solutions; Temperature | 1996 |
Reactive oxygen metabolites increase mitochondrial calcium in endothelial cells: implication of the Ca2+/Na+ exchanger.
Topics: Adenosine Triphosphate; Aequorin; Benzimidazoles; Calcium; Carbocyanines; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Line; Clonazepam; Cytosol; Dose-Response Relationship, Drug; Endothelium; Enzyme Inhibitors; Flow Cytometry; Histamine; Humans; Hydrogen Peroxide; Indoles; Mitochondria; Reactive Oxygen Species; Sodium-Calcium Exchanger; Thiazepines; Time Factors; Transfection; Umbilical Veins; Xanthine Oxidase | 1999 |